Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Muscle Vibration for the Treatment of Peripheral Neuropathy-Associated Gait Dysfunction

Trial Status: closed to accrual

This pilot trial evaluates whether a vibrating device can improve walking ability (gait) in patients who have peripheral neuropathy-associated gait dysfunction. Peripheral neuropathy is a disorder of the peripheral nervous system that manifests as pain, tingling, numbness, and muscle weakness. It is a common diagnosis among people with cancer and especially those who have undergone chemotherapy. Individual muscle vibration has the potential to improve disordered gait, but there is not a commercially available vibration system available, and there are still many questions surrounding the outcomes of the use of this treatment. This pilot trial seeks to answer some of those questions.